Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase - Deficient mice by adenovirus-mediated expression of human lipoprotein lipase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2532-2539

  Ashbourne Excoffon, Katherine J D ^a   Liu, Guoqing ^a   Miao, Li ^a   Wilson, Janet E ^a   McManus, Bruce M ^a   Semenkovich, Clay F ^b   Coleman, Trey ^b   Benoit, Patrick ^c   Duverger, Nicolas ^c   Branellec, Didier ^c   Denefle, Patrice ^c   Hayden, Michael R ^a   Lewis, M E Suzanne ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b WASHINGTON UNIVERSITY   (United States)

^c SANOFI   (France)

Author keywords

Adenovirus; Animal models; Chylomicronemia; Gene therapy; Lipolysis

Indexed keywords

BETA GALACTOSIDASE; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE THERAPY; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; IN SITU HYBRIDIZATION; LIPOLYSIS; LIPOPROTEIN METABOLISM; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 17344366287     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.17.11.2532     Document Type: Article

References (15)

1. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly D, Valle D, eds. Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill Book Co; 1995:1913-1932.
2. Gagne C, Brun LD, Julien P, Moorjani S, Lupien PJ. Primary lipoprotein lipase activity deficiency: clinical investigation of a French Canadian population. Can Med Assoc J. 1989;140:405-411.
3. Reymer PWA, Gagne E, Groenmeyer BE, Zhang H, Forsythe I, Jansen H, Seidel JCI, Kromhout D, Lie KE, Kastelein JJ, Hayden MR. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet. 1995;10:28-34.
4. Bijvoet S, Gagne E, Moorjani S, Gagne C, Henderson HE, Fruchart J-C, Dallongeville J, Alaupovic P, M. Prins, Kastelein JJ, Hayden MR. Alterations in plasma lipoproteins and apoli- . poproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res. 1996;37:640-650.
5. Mailly F, Fisher R.M, Nicaud V, Luong LA, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study. Atherosclerosis. 1996; 122:21-28.
6. Jukema JW, van Boven AI, Groenmeijer B, Zwinderman AH, Reiber JH, Bruschke AV, Henneman JA, Molhoek GP, Bruin T, Jansen H, Gagne E, Hayden MR, Kastelein JJ. The Asp9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation. 1996;94: 1913-1918.
7. Ma Y, Liu M-S, Ginzinger D, Frohlich J, Brunzell JD, Hayden MR. Gene-environment interaction in the conversion of a mild to severe phenotype in a patient homozygous for a Ser172Cys mutation in the J. lipoprotein lipase gene. J Clin Invest. 1993;91:1953-1958.
8. Hayden MR, Liu M-S, Ma Y. Gene environment interaction and plasma triglyceride levels: the crucial role of lipoprotein lipase. Clin Genet. 1994;46:15-18.
9. Miesenbock G, Holzl B, Foger B, Brandstatter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 1993;91:448-455.
10. Pimstone, SN, Clee SM, Gagne SE, Miao L, Zhang H, Stein EA, Hayden MR. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res. 1996;37:1-10.
11. Benlien P, De Gennes JL, Foubert L, Zhang H, Gagne SE, Hayden MR. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 1996;335:848-854.
12. Gnudi L, Jensen DR, Tozzo E, Eckel RH, Kahn BB. Adipose-specific overexpression of GLUT-4 in transgenic mice alters lipoprotein lipase activity. Am J Physiol. 1996;270:785-792.
13. Levak-Frank S, Radner H, Walsh A, Stollberger R, Knipping G, Hoefler G, Sattler W, Weisnstock PH, Breslow JL, Zechner R. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest. 1995;96:976-986.
14. Liu M-S, Jirik FR, Leboeuf RC, Henderson H, Castellani LW, Lusis AT, Ma Y, Forsythe IJ, Zhang H, Kirk E, Brunzell JD, Hayden MR. Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. J Biol Chem. 1994;269: 11417-11424.
15. Shimada M, Shimano H, Gotoda T, Yamamoto K, Kawamura M, Inaba T, Yazaki Y, Yamada N. Overexpression of human lipoprotein lipase in transgenic mice. J Biol Chem. 1993;268:17924-17929.